Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds

Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, Csrc, Src, PRK2, FGFR3, Flt3, Lck, Mekl, PDK-1, GSK3 , EGFR, P70s6k, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animal...

Full description

Saved in:
Bibliographic Details
Main Authors STEINIG, ARNO G, KITCHIN, JOHN, SABA, IMAAD, SAMBROOK SMITH, COLIN PETER, FOREMAN, KENNETH, TAVARES, PAULA, DAWSON, GRAHAM, PANICKER, BIJOY, SADIQ, SHAZIA, WENG, QINGHUA, COX, MATTHEW, GATTRELL, WILLIAM, WILKES, ROBIN, BARBA, OSCAR, AHMED, SALEH, LI, AN-HU, PEGG, NEIL ANTHONY, SMYTH, DON, BLOXHAM, JASON, MA, LI FU, DONG, HANQING, STOLZ, KATHRYN
Format Patent
LanguageChinese
English
Published 16.05.2006
Online AccessGet full text

Cover

More Information
Summary:Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, Csrc, Src, PRK2, FGFR3, Flt3, Lck, Mekl, PDK-1, GSK3 , EGFR, P70s6k, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animals, including humans, for the treatment and/or prevention of various diseases and conditions such as cancer.
Bibliography:Application Number: TW200594126065